title: Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro.
abstract: For the adoptive immunotherapy in immunodeficient bone marrow transplant recipients to prevent and treat human cytomegalovirus (HCMV)-associated diseases, HCMV-pulsed dendritic cells (DCs) were used as antigen-presenting cells for the induction of cytotoxic T lymphocytes (CTLs) specific to HCMV antigens in vitro. The antiviral CTL responses induced by HCMV-pulsed DCs were as highly efficient as those induced by HCMV-infected dermal fibroblasts, and endogenous viral gene expression was not required to induce virus-specific T-cell lines. The strong cytotoxic activity against HCMV-pp65, known as HCMV major antigen, was identified using autologous B lymphoblastoid cell line expressing pp65 antigen. The cytotoxic activity toward HCMV-infected target cells was found to be mediated primarily by CD8+ T cells, although both CD8+ cells and CD4+ cells were able to lyse autologous virus-infected target cells. The CTLs contained a mixture of effector cells that recognized virus peptides in the context of major histocompatibility complex. This system may be useful for defining the cellular immune response to HCMV and for the treatment of HCMV infection in immunocompromised patients.
authors.affiliation: Department of Microbiology and Immunology, College of Medicine, Catholic Hematopoietic Stem Cell Transplantation Center, The Catholic University of Korea, Seoul.
authors.forename: H I
authors.initials: HI
authors.lastname: Cho
authors.forename: H
authors.initials: H
authors.lastname: Han
authors.forename: C C
authors.initials: CC
authors.lastname: Kim
authors.forename: T G
authors.initials: TG
authors.lastname: Kim
mesh_terms: D017951:Antigen Presentation; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000276:immunology / Q000517:prevention & control / Q000628:therapy; D003713:Dendritic Cells / Q000276:immunology*; D005347:Fibroblasts / Q000276:immunology; D006680:HLA Antigens; D006801:Humans; D016867:Immunocompromised Host; D016219:Immunotherapy, Adoptive; D066298:In Vitro Techniques; D016131:Lymphocyte Subsets / Q000276:immunology; D012867:Skin / Q000166:cytology / Q000293:injuries; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D006680:HLA Antigens